Analysts expect TScan Therapeutics, Inc. to report revenue of 1.15 M for Q4 26, against a range of 1.10 M to 1.19 M. The most recent reported quarter, Q3 26, came in at 586,000.00, a 36.3% beat against the 429,910.88 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 665,000.00 | 2.17 M | 3.08 M | 2.51 M | 2.57 M | 982,000.00 | 1.05 M | 586,000.00 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 1.49 M | 1.13 M | 1.50 M | 1.94 M | 2.74 M | 2.53 M | 2.08 M | 460,358.89 | 1.19 M | 1.06 M | 971,777.48 | 932,356.73 | 1.14 M | 904,009.64 | 1.12 M | 926,374.79 | |||||||||
| Low Estimate | 1.35 M | 934,454.77 | 1.24 M | 1.80 M | 2.42 M | 2.32 M | 1.87 M | 399,462.87 | 1.10 M | 930,281.97 | 826,981.02 | 787,273.27 | 998,811.48 | 807,293.62 | 1.00 M | 790,345.33 | |||||||||
| Consensus Estimate | 1.42 M | 1.03 M | 1.37 M | 1.87 M | 2.58 M | 2.42 M | 1.98 M | 429,910.88 | 1.15 M | 993,719.00 | 899,379.25 | 859,815.00 | 1.07 M | 855,651.63 | 1.06 M | 858,360.06 |
Analysts expect TScan Therapeutics, Inc. to report earnings per share of -0.15 for Q4 26, against a range of -0.16 to -0.14. The most recent reported quarter, Q3 26, came in at -0.25, a 31.6% miss against the -0.19 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.30 | -0.26 | -0.28 | -0.28 | -0.18 | -0.22 | -0.23 | -0.25 | - | - | - | - |
| High Estimate | -0.32 | -0.27 | -0.33 | -0.30 | -0.25 | -0.18 | -0.23 | -0.18 | -0.14 | -0.14 | -0.14 | -0.13 |
| Low Estimate | -0.36 | -0.33 | -0.35 | -0.34 | -0.27 | -0.20 | -0.25 | -0.20 | -0.16 | -0.16 | -0.16 | -0.15 |
| Consensus Estimate | -0.34 | -0.30 | -0.34 | -0.32 | -0.26 | -0.19 | -0.24 | -0.19 | -0.15 | -0.15 | -0.15 | -0.14 |
Pull Wall Street consensus for TScan Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=TCRX&mode=revenue&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "TCRX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/estimates?ticker=TCRX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();